TAILIN: Zhejiang Tailin Biotech Co., Ltd. entrusted management report for convertible corporate bonds issued to unspecified objects (2023)
TAILIN: 2021, Zhejiang Tailin Biotechnology Co., Ltd. issued convertible corporate bonds on the Growth Enterprise Market to unspecified parties. This report tracks the rating until 2024.
TAILIN: Announcement Regarding the Acquisition of a Patent Certificate
TAILIN: Notice on Obtaining Patent Certificates and Software Copyright Registration Certificates
TAILIN: 300813 Tailin Biotech Investor Relations Management Information 20240522
TAILIN: Announcement on changes in the rights and interests of controlling shareholders, actual controllers, and their concerted actors to reach 1%
TAILIN: Announcement on the completion of the sale of some special accounts to raise capital for initial public offering of shares
TAILIN: Announcement on the adjustment of Tailin's debt-for-equity conversion price
TAILIN: 2023 Equity Distribution Implementation Notice
TAILIN: Announcement on the completion of the election of the Board of Directors for a new term
TAILIN: Legal Opinion of Guo Hao (Hangzhou) Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Tailin Biotechnology Co., Ltd.
TAILIN: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
TAILIN: Announcement on the completion of the election of the Board of Supervisors for a new term
TAILIN: Announcement of Resolutions of the First Meeting of the Fourth Board of Supervisors
TAILIN: Announcement on the appointment of senior management personnel, securities affairs representatives and heads of internal audit departments
TAILIN: Announcement of Resolutions of the First Meeting of the Fourth Board of Directors
TAILIN: Great Wall Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Zhejiang Tailin Biotechnology Co., Ltd.
TAILIN: Great Wall Securities Co., Ltd. report on the 2023 continuous supervision and regular on-site inspection report of Zhejiang Tailin Biotechnology Co., Ltd.
TAILIN: Notice of abnormal fluctuations in stock trading
TAILIN: 300813 Tailin Biotech Investor Relations Management Information 20240507
No Data